Global Oligonucleotide (Oligo) Drugs Supply, Demand and Key Producers, 2024-2030
The global Oligonucleotide (Oligo) Drugs market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Oligonucleotides (oligonucleotides for short) drugs are a type of drug molecules based on oligonucleotide structures, used to treat specific diseases. These drugs take advantage of the sequence selectivity, biomolecule recognition, and gene expression regulation of oligonucleotides to regulate the biological processes of diseases.
This report studies the global Oligonucleotide (Oligo) Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oligonucleotide (Oligo) Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oligonucleotide (Oligo) Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oligonucleotide (Oligo) Drugs total production and demand, 2019-2030, (K Units)
Global Oligonucleotide (Oligo) Drugs total production value, 2019-2030, (USD Million)
Global Oligonucleotide (Oligo) Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Oligonucleotide (Oligo) Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Oligonucleotide (Oligo) Drugs domestic production, consumption, key domestic manufacturers and share
Global Oligonucleotide (Oligo) Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Oligonucleotide (Oligo) Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Oligonucleotide (Oligo) Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Oligonucleotide (Oligo) Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonis, Biogen, Sarepta, Novartis, Antisense Therapeutics, Akcea, Ruibo Biotechnology, Inois and Therapeutics Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oligonucleotide (Oligo) Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Oligonucleotide (Oligo) Drugs Market, By Region:
1. How big is the global Oligonucleotide (Oligo) Drugs market?
2. What is the demand of the global Oligonucleotide (Oligo) Drugs market?
3. What is the year over year growth of the global Oligonucleotide (Oligo) Drugs market?
4. What is the production and production value of the global Oligonucleotide (Oligo) Drugs market?
5. Who are the key producers in the global Oligonucleotide (Oligo) Drugs market?
Oligonucleotides (oligonucleotides for short) drugs are a type of drug molecules based on oligonucleotide structures, used to treat specific diseases. These drugs take advantage of the sequence selectivity, biomolecule recognition, and gene expression regulation of oligonucleotides to regulate the biological processes of diseases.
This report studies the global Oligonucleotide (Oligo) Drugs production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Oligonucleotide (Oligo) Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oligonucleotide (Oligo) Drugs that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Oligonucleotide (Oligo) Drugs total production and demand, 2019-2030, (K Units)
Global Oligonucleotide (Oligo) Drugs total production value, 2019-2030, (USD Million)
Global Oligonucleotide (Oligo) Drugs production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Oligonucleotide (Oligo) Drugs consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Oligonucleotide (Oligo) Drugs domestic production, consumption, key domestic manufacturers and share
Global Oligonucleotide (Oligo) Drugs production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Oligonucleotide (Oligo) Drugs production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Oligonucleotide (Oligo) Drugs production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Oligonucleotide (Oligo) Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lonis, Biogen, Sarepta, Novartis, Antisense Therapeutics, Akcea, Ruibo Biotechnology, Inois and Therapeutics Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oligonucleotide (Oligo) Drugs market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Oligonucleotide (Oligo) Drugs Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- siRNA
- Antisense Oligonucleotide
- Hospital
- Clinic
- Lonis
- Biogen
- Sarepta
- Novartis
- Antisense Therapeutics
- Akcea
- Ruibo Biotechnology
- Inois
- Therapeutics Inc.
- Sanofi
1. How big is the global Oligonucleotide (Oligo) Drugs market?
2. What is the demand of the global Oligonucleotide (Oligo) Drugs market?
3. What is the year over year growth of the global Oligonucleotide (Oligo) Drugs market?
4. What is the production and production value of the global Oligonucleotide (Oligo) Drugs market?
5. Who are the key producers in the global Oligonucleotide (Oligo) Drugs market?
1 SUPPLY SUMMARY
1.1 Oligonucleotide (Oligo) Drugs Introduction
1.2 World Oligonucleotide (Oligo) Drugs Supply & Forecast
1.2.1 World Oligonucleotide (Oligo) Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World Oligonucleotide (Oligo) Drugs Production (2019-2030)
1.2.3 World Oligonucleotide (Oligo) Drugs Pricing Trends (2019-2030)
1.3 World Oligonucleotide (Oligo) Drugs Production by Region (Based on Production Site)
1.3.1 World Oligonucleotide (Oligo) Drugs Production Value by Region (2019-2030)
1.3.2 World Oligonucleotide (Oligo) Drugs Production by Region (2019-2030)
1.3.3 World Oligonucleotide (Oligo) Drugs Average Price by Region (2019-2030)
1.3.4 North America Oligonucleotide (Oligo) Drugs Production (2019-2030)
1.3.5 Europe Oligonucleotide (Oligo) Drugs Production (2019-2030)
1.3.6 China Oligonucleotide (Oligo) Drugs Production (2019-2030)
1.3.7 Japan Oligonucleotide (Oligo) Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oligonucleotide (Oligo) Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oligonucleotide (Oligo) Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Oligonucleotide (Oligo) Drugs Demand (2019-2030)
2.2 World Oligonucleotide (Oligo) Drugs Consumption by Region
2.2.1 World Oligonucleotide (Oligo) Drugs Consumption by Region (2019-2024)
2.2.2 World Oligonucleotide (Oligo) Drugs Consumption Forecast by Region (2025-2030)
2.3 United States Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
2.4 China Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
2.5 Europe Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
2.6 Japan Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
2.7 South Korea Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
2.8 ASEAN Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
2.9 India Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
3 WORLD OLIGONUCLEOTIDE (OLIGO) DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oligonucleotide (Oligo) Drugs Production Value by Manufacturer (2019-2024)
3.2 World Oligonucleotide (Oligo) Drugs Production by Manufacturer (2019-2024)
3.3 World Oligonucleotide (Oligo) Drugs Average Price by Manufacturer (2019-2024)
3.4 Oligonucleotide (Oligo) Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oligonucleotide (Oligo) Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oligonucleotide (Oligo) Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for Oligonucleotide (Oligo) Drugs in 2023
3.6 Oligonucleotide (Oligo) Drugs Market: Overall Company Footprint Analysis
3.6.1 Oligonucleotide (Oligo) Drugs Market: Region Footprint
3.6.2 Oligonucleotide (Oligo) Drugs Market: Company Product Type Footprint
3.6.3 Oligonucleotide (Oligo) Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oligonucleotide (Oligo) Drugs Production Value Comparison
4.1.1 United States VS China: Oligonucleotide (Oligo) Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Oligonucleotide (Oligo) Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Oligonucleotide (Oligo) Drugs Production Comparison
4.2.1 United States VS China: Oligonucleotide (Oligo) Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Oligonucleotide (Oligo) Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Oligonucleotide (Oligo) Drugs Consumption Comparison
4.3.1 United States VS China: Oligonucleotide (Oligo) Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Oligonucleotide (Oligo) Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Oligonucleotide (Oligo) Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Oligonucleotide (Oligo) Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production (2019-2024)
4.5 China Based Oligonucleotide (Oligo) Drugs Manufacturers and Market Share
4.5.1 China Based Oligonucleotide (Oligo) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers Oligonucleotide (Oligo) Drugs Production (2019-2024)
4.6 Rest of World Based Oligonucleotide (Oligo) Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Oligonucleotide (Oligo) Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Oligonucleotide (Oligo) Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 siRNA
5.2.2 Antisense Oligonucleotide
5.3 Market Segment by Type
5.3.1 World Oligonucleotide (Oligo) Drugs Production by Type (2019-2030)
5.3.2 World Oligonucleotide (Oligo) Drugs Production Value by Type (2019-2030)
5.3.3 World Oligonucleotide (Oligo) Drugs Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oligonucleotide (Oligo) Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Oligonucleotide (Oligo) Drugs Production by Application (2019-2030)
6.3.2 World Oligonucleotide (Oligo) Drugs Production Value by Application (2019-2030)
6.3.3 World Oligonucleotide (Oligo) Drugs Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Lonis
7.1.1 Lonis Details
7.1.2 Lonis Major Business
7.1.3 Lonis Oligonucleotide (Oligo) Drugs Product and Services
7.1.4 Lonis Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Lonis Recent Developments/Updates
7.1.6 Lonis Competitive Strengths & Weaknesses
7.2 Biogen
7.2.1 Biogen Details
7.2.2 Biogen Major Business
7.2.3 Biogen Oligonucleotide (Oligo) Drugs Product and Services
7.2.4 Biogen Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Biogen Recent Developments/Updates
7.2.6 Biogen Competitive Strengths & Weaknesses
7.3 Sarepta
7.3.1 Sarepta Details
7.3.2 Sarepta Major Business
7.3.3 Sarepta Oligonucleotide (Oligo) Drugs Product and Services
7.3.4 Sarepta Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Sarepta Recent Developments/Updates
7.3.6 Sarepta Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Oligonucleotide (Oligo) Drugs Product and Services
7.4.4 Novartis Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Antisense Therapeutics
7.5.1 Antisense Therapeutics Details
7.5.2 Antisense Therapeutics Major Business
7.5.3 Antisense Therapeutics Oligonucleotide (Oligo) Drugs Product and Services
7.5.4 Antisense Therapeutics Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Antisense Therapeutics Recent Developments/Updates
7.5.6 Antisense Therapeutics Competitive Strengths & Weaknesses
7.6 Akcea
7.6.1 Akcea Details
7.6.2 Akcea Major Business
7.6.3 Akcea Oligonucleotide (Oligo) Drugs Product and Services
7.6.4 Akcea Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Akcea Recent Developments/Updates
7.6.6 Akcea Competitive Strengths & Weaknesses
7.7 Ruibo Biotechnology
7.7.1 Ruibo Biotechnology Details
7.7.2 Ruibo Biotechnology Major Business
7.7.3 Ruibo Biotechnology Oligonucleotide (Oligo) Drugs Product and Services
7.7.4 Ruibo Biotechnology Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Ruibo Biotechnology Recent Developments/Updates
7.7.6 Ruibo Biotechnology Competitive Strengths & Weaknesses
7.8 Inois
7.8.1 Inois Details
7.8.2 Inois Major Business
7.8.3 Inois Oligonucleotide (Oligo) Drugs Product and Services
7.8.4 Inois Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Inois Recent Developments/Updates
7.8.6 Inois Competitive Strengths & Weaknesses
7.9 Therapeutics Inc.
7.9.1 Therapeutics Inc. Details
7.9.2 Therapeutics Inc. Major Business
7.9.3 Therapeutics Inc. Oligonucleotide (Oligo) Drugs Product and Services
7.9.4 Therapeutics Inc. Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Therapeutics Inc. Recent Developments/Updates
7.9.6 Therapeutics Inc. Competitive Strengths & Weaknesses
7.10 Sanofi
7.10.1 Sanofi Details
7.10.2 Sanofi Major Business
7.10.3 Sanofi Oligonucleotide (Oligo) Drugs Product and Services
7.10.4 Sanofi Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Sanofi Recent Developments/Updates
7.10.6 Sanofi Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oligonucleotide (Oligo) Drugs Industry Chain
8.2 Oligonucleotide (Oligo) Drugs Upstream Analysis
8.2.1 Oligonucleotide (Oligo) Drugs Core Raw Materials
8.2.2 Main Manufacturers of Oligonucleotide (Oligo) Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Oligonucleotide (Oligo) Drugs Production Mode
8.6 Oligonucleotide (Oligo) Drugs Procurement Model
8.7 Oligonucleotide (Oligo) Drugs Industry Sales Model and Sales Channels
8.7.1 Oligonucleotide (Oligo) Drugs Sales Model
8.7.2 Oligonucleotide (Oligo) Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Oligonucleotide (Oligo) Drugs Introduction
1.2 World Oligonucleotide (Oligo) Drugs Supply & Forecast
1.2.1 World Oligonucleotide (Oligo) Drugs Production Value (2019 & 2023 & 2030)
1.2.2 World Oligonucleotide (Oligo) Drugs Production (2019-2030)
1.2.3 World Oligonucleotide (Oligo) Drugs Pricing Trends (2019-2030)
1.3 World Oligonucleotide (Oligo) Drugs Production by Region (Based on Production Site)
1.3.1 World Oligonucleotide (Oligo) Drugs Production Value by Region (2019-2030)
1.3.2 World Oligonucleotide (Oligo) Drugs Production by Region (2019-2030)
1.3.3 World Oligonucleotide (Oligo) Drugs Average Price by Region (2019-2030)
1.3.4 North America Oligonucleotide (Oligo) Drugs Production (2019-2030)
1.3.5 Europe Oligonucleotide (Oligo) Drugs Production (2019-2030)
1.3.6 China Oligonucleotide (Oligo) Drugs Production (2019-2030)
1.3.7 Japan Oligonucleotide (Oligo) Drugs Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Oligonucleotide (Oligo) Drugs Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Oligonucleotide (Oligo) Drugs Major Market Trends
2 DEMAND SUMMARY
2.1 World Oligonucleotide (Oligo) Drugs Demand (2019-2030)
2.2 World Oligonucleotide (Oligo) Drugs Consumption by Region
2.2.1 World Oligonucleotide (Oligo) Drugs Consumption by Region (2019-2024)
2.2.2 World Oligonucleotide (Oligo) Drugs Consumption Forecast by Region (2025-2030)
2.3 United States Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
2.4 China Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
2.5 Europe Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
2.6 Japan Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
2.7 South Korea Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
2.8 ASEAN Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
2.9 India Oligonucleotide (Oligo) Drugs Consumption (2019-2030)
3 WORLD OLIGONUCLEOTIDE (OLIGO) DRUGS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Oligonucleotide (Oligo) Drugs Production Value by Manufacturer (2019-2024)
3.2 World Oligonucleotide (Oligo) Drugs Production by Manufacturer (2019-2024)
3.3 World Oligonucleotide (Oligo) Drugs Average Price by Manufacturer (2019-2024)
3.4 Oligonucleotide (Oligo) Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Oligonucleotide (Oligo) Drugs Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Oligonucleotide (Oligo) Drugs in 2023
3.5.3 Global Concentration Ratios (CR8) for Oligonucleotide (Oligo) Drugs in 2023
3.6 Oligonucleotide (Oligo) Drugs Market: Overall Company Footprint Analysis
3.6.1 Oligonucleotide (Oligo) Drugs Market: Region Footprint
3.6.2 Oligonucleotide (Oligo) Drugs Market: Company Product Type Footprint
3.6.3 Oligonucleotide (Oligo) Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Oligonucleotide (Oligo) Drugs Production Value Comparison
4.1.1 United States VS China: Oligonucleotide (Oligo) Drugs Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Oligonucleotide (Oligo) Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Oligonucleotide (Oligo) Drugs Production Comparison
4.2.1 United States VS China: Oligonucleotide (Oligo) Drugs Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Oligonucleotide (Oligo) Drugs Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Oligonucleotide (Oligo) Drugs Consumption Comparison
4.3.1 United States VS China: Oligonucleotide (Oligo) Drugs Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Oligonucleotide (Oligo) Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Oligonucleotide (Oligo) Drugs Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Oligonucleotide (Oligo) Drugs Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value (2019-2024)
4.4.3 United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production (2019-2024)
4.5 China Based Oligonucleotide (Oligo) Drugs Manufacturers and Market Share
4.5.1 China Based Oligonucleotide (Oligo) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value (2019-2024)
4.5.3 China Based Manufacturers Oligonucleotide (Oligo) Drugs Production (2019-2024)
4.6 Rest of World Based Oligonucleotide (Oligo) Drugs Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Oligonucleotide (Oligo) Drugs Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Oligonucleotide (Oligo) Drugs Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 siRNA
5.2.2 Antisense Oligonucleotide
5.3 Market Segment by Type
5.3.1 World Oligonucleotide (Oligo) Drugs Production by Type (2019-2030)
5.3.2 World Oligonucleotide (Oligo) Drugs Production Value by Type (2019-2030)
5.3.3 World Oligonucleotide (Oligo) Drugs Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Oligonucleotide (Oligo) Drugs Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Segment by Application
6.3.1 World Oligonucleotide (Oligo) Drugs Production by Application (2019-2030)
6.3.2 World Oligonucleotide (Oligo) Drugs Production Value by Application (2019-2030)
6.3.3 World Oligonucleotide (Oligo) Drugs Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Lonis
7.1.1 Lonis Details
7.1.2 Lonis Major Business
7.1.3 Lonis Oligonucleotide (Oligo) Drugs Product and Services
7.1.4 Lonis Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Lonis Recent Developments/Updates
7.1.6 Lonis Competitive Strengths & Weaknesses
7.2 Biogen
7.2.1 Biogen Details
7.2.2 Biogen Major Business
7.2.3 Biogen Oligonucleotide (Oligo) Drugs Product and Services
7.2.4 Biogen Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Biogen Recent Developments/Updates
7.2.6 Biogen Competitive Strengths & Weaknesses
7.3 Sarepta
7.3.1 Sarepta Details
7.3.2 Sarepta Major Business
7.3.3 Sarepta Oligonucleotide (Oligo) Drugs Product and Services
7.3.4 Sarepta Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Sarepta Recent Developments/Updates
7.3.6 Sarepta Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Oligonucleotide (Oligo) Drugs Product and Services
7.4.4 Novartis Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Antisense Therapeutics
7.5.1 Antisense Therapeutics Details
7.5.2 Antisense Therapeutics Major Business
7.5.3 Antisense Therapeutics Oligonucleotide (Oligo) Drugs Product and Services
7.5.4 Antisense Therapeutics Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Antisense Therapeutics Recent Developments/Updates
7.5.6 Antisense Therapeutics Competitive Strengths & Weaknesses
7.6 Akcea
7.6.1 Akcea Details
7.6.2 Akcea Major Business
7.6.3 Akcea Oligonucleotide (Oligo) Drugs Product and Services
7.6.4 Akcea Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Akcea Recent Developments/Updates
7.6.6 Akcea Competitive Strengths & Weaknesses
7.7 Ruibo Biotechnology
7.7.1 Ruibo Biotechnology Details
7.7.2 Ruibo Biotechnology Major Business
7.7.3 Ruibo Biotechnology Oligonucleotide (Oligo) Drugs Product and Services
7.7.4 Ruibo Biotechnology Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Ruibo Biotechnology Recent Developments/Updates
7.7.6 Ruibo Biotechnology Competitive Strengths & Weaknesses
7.8 Inois
7.8.1 Inois Details
7.8.2 Inois Major Business
7.8.3 Inois Oligonucleotide (Oligo) Drugs Product and Services
7.8.4 Inois Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Inois Recent Developments/Updates
7.8.6 Inois Competitive Strengths & Weaknesses
7.9 Therapeutics Inc.
7.9.1 Therapeutics Inc. Details
7.9.2 Therapeutics Inc. Major Business
7.9.3 Therapeutics Inc. Oligonucleotide (Oligo) Drugs Product and Services
7.9.4 Therapeutics Inc. Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Therapeutics Inc. Recent Developments/Updates
7.9.6 Therapeutics Inc. Competitive Strengths & Weaknesses
7.10 Sanofi
7.10.1 Sanofi Details
7.10.2 Sanofi Major Business
7.10.3 Sanofi Oligonucleotide (Oligo) Drugs Product and Services
7.10.4 Sanofi Oligonucleotide (Oligo) Drugs Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Sanofi Recent Developments/Updates
7.10.6 Sanofi Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Oligonucleotide (Oligo) Drugs Industry Chain
8.2 Oligonucleotide (Oligo) Drugs Upstream Analysis
8.2.1 Oligonucleotide (Oligo) Drugs Core Raw Materials
8.2.2 Main Manufacturers of Oligonucleotide (Oligo) Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Oligonucleotide (Oligo) Drugs Production Mode
8.6 Oligonucleotide (Oligo) Drugs Procurement Model
8.7 Oligonucleotide (Oligo) Drugs Industry Sales Model and Sales Channels
8.7.1 Oligonucleotide (Oligo) Drugs Sales Model
8.7.2 Oligonucleotide (Oligo) Drugs Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Oligonucleotide (Oligo) Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Oligonucleotide (Oligo) Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World Oligonucleotide (Oligo) Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Region (2019-2024)
Table 5. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Region (2025-2030)
Table 6. World Oligonucleotide (Oligo) Drugs Production by Region (2019-2024) & (K Units)
Table 7. World Oligonucleotide (Oligo) Drugs Production by Region (2025-2030) & (K Units)
Table 8. World Oligonucleotide (Oligo) Drugs Production Market Share by Region (2019-2024)
Table 9. World Oligonucleotide (Oligo) Drugs Production Market Share by Region (2025-2030)
Table 10. World Oligonucleotide (Oligo) Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Oligonucleotide (Oligo) Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Oligonucleotide (Oligo) Drugs Major Market Trends
Table 13. World Oligonucleotide (Oligo) Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Oligonucleotide (Oligo) Drugs Consumption by Region (2019-2024) & (K Units)
Table 15. World Oligonucleotide (Oligo) Drugs Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Oligonucleotide (Oligo) Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Oligonucleotide (Oligo) Drugs Producers in 2023
Table 18. World Oligonucleotide (Oligo) Drugs Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Oligonucleotide (Oligo) Drugs Producers in 2023
Table 20. World Oligonucleotide (Oligo) Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Oligonucleotide (Oligo) Drugs Company Evaluation Quadrant
Table 22. World Oligonucleotide (Oligo) Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Oligonucleotide (Oligo) Drugs Production Site of Key Manufacturer
Table 24. Oligonucleotide (Oligo) Drugs Market: Company Product Type Footprint
Table 25. Oligonucleotide (Oligo) Drugs Market: Company Product Application Footprint
Table 26. Oligonucleotide (Oligo) Drugs Competitive Factors
Table 27. Oligonucleotide (Oligo) Drugs New Entrant and Capacity Expansion Plans
Table 28. Oligonucleotide (Oligo) Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Oligonucleotide (Oligo) Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Oligonucleotide (Oligo) Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Oligonucleotide (Oligo) Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Oligonucleotide (Oligo) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production Market Share (2019-2024)
Table 37. China Based Oligonucleotide (Oligo) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Oligonucleotide (Oligo) Drugs Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Oligonucleotide (Oligo) Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based Oligonucleotide (Oligo) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production Market Share (2019-2024)
Table 47. World Oligonucleotide (Oligo) Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Oligonucleotide (Oligo) Drugs Production by Type (2019-2024) & (K Units)
Table 49. World Oligonucleotide (Oligo) Drugs Production by Type (2025-2030) & (K Units)
Table 50. World Oligonucleotide (Oligo) Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World Oligonucleotide (Oligo) Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World Oligonucleotide (Oligo) Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Oligonucleotide (Oligo) Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Oligonucleotide (Oligo) Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Oligonucleotide (Oligo) Drugs Production by Application (2019-2024) & (K Units)
Table 56. World Oligonucleotide (Oligo) Drugs Production by Application (2025-2030) & (K Units)
Table 57. World Oligonucleotide (Oligo) Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World Oligonucleotide (Oligo) Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World Oligonucleotide (Oligo) Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Oligonucleotide (Oligo) Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Lonis Basic Information, Manufacturing Base and Competitors
Table 62. Lonis Major Business
Table 63. Lonis Oligonucleotide (Oligo) Drugs Product and Services
Table 64. Lonis Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Lonis Recent Developments/Updates
Table 66. Lonis Competitive Strengths & Weaknesses
Table 67. Biogen Basic Information, Manufacturing Base and Competitors
Table 68. Biogen Major Business
Table 69. Biogen Oligonucleotide (Oligo) Drugs Product and Services
Table 70. Biogen Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Biogen Recent Developments/Updates
Table 72. Biogen Competitive Strengths & Weaknesses
Table 73. Sarepta Basic Information, Manufacturing Base and Competitors
Table 74. Sarepta Major Business
Table 75. Sarepta Oligonucleotide (Oligo) Drugs Product and Services
Table 76. Sarepta Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Sarepta Recent Developments/Updates
Table 78. Sarepta Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Oligonucleotide (Oligo) Drugs Product and Services
Table 82. Novartis Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Antisense Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Antisense Therapeutics Major Business
Table 87. Antisense Therapeutics Oligonucleotide (Oligo) Drugs Product and Services
Table 88. Antisense Therapeutics Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Antisense Therapeutics Recent Developments/Updates
Table 90. Antisense Therapeutics Competitive Strengths & Weaknesses
Table 91. Akcea Basic Information, Manufacturing Base and Competitors
Table 92. Akcea Major Business
Table 93. Akcea Oligonucleotide (Oligo) Drugs Product and Services
Table 94. Akcea Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Akcea Recent Developments/Updates
Table 96. Akcea Competitive Strengths & Weaknesses
Table 97. Ruibo Biotechnology Basic Information, Manufacturing Base and Competitors
Table 98. Ruibo Biotechnology Major Business
Table 99. Ruibo Biotechnology Oligonucleotide (Oligo) Drugs Product and Services
Table 100. Ruibo Biotechnology Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Ruibo Biotechnology Recent Developments/Updates
Table 102. Ruibo Biotechnology Competitive Strengths & Weaknesses
Table 103. Inois Basic Information, Manufacturing Base and Competitors
Table 104. Inois Major Business
Table 105. Inois Oligonucleotide (Oligo) Drugs Product and Services
Table 106. Inois Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Inois Recent Developments/Updates
Table 108. Inois Competitive Strengths & Weaknesses
Table 109. Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Therapeutics Inc. Major Business
Table 111. Therapeutics Inc. Oligonucleotide (Oligo) Drugs Product and Services
Table 112. Therapeutics Inc. Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Therapeutics Inc. Recent Developments/Updates
Table 114. Sanofi Basic Information, Manufacturing Base and Competitors
Table 115. Sanofi Major Business
Table 116. Sanofi Oligonucleotide (Oligo) Drugs Product and Services
Table 117. Sanofi Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 118. Global Key Players of Oligonucleotide (Oligo) Drugs Upstream (Raw Materials)
Table 119. Oligonucleotide (Oligo) Drugs Typical Customers
Table 120. Oligonucleotide (Oligo) Drugs Typical Distributors
LIST OF FIGURE
Figure 1. Oligonucleotide (Oligo) Drugs Picture
Figure 2. World Oligonucleotide (Oligo) Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Oligonucleotide (Oligo) Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Oligonucleotide (Oligo) Drugs Production (2019-2030) & (K Units)
Figure 5. World Oligonucleotide (Oligo) Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World Oligonucleotide (Oligo) Drugs Production Market Share by Region (2019-2030)
Figure 8. North America Oligonucleotide (Oligo) Drugs Production (2019-2030) & (K Units)
Figure 9. Europe Oligonucleotide (Oligo) Drugs Production (2019-2030) & (K Units)
Figure 10. China Oligonucleotide (Oligo) Drugs Production (2019-2030) & (K Units)
Figure 11. Japan Oligonucleotide (Oligo) Drugs Production (2019-2030) & (K Units)
Figure 12. Oligonucleotide (Oligo) Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 15. World Oligonucleotide (Oligo) Drugs Consumption Market Share by Region (2019-2030)
Figure 16. United States Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 17. China Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 18. Europe Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 19. Japan Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 20. South Korea Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 22. India Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Oligonucleotide (Oligo) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oligonucleotide (Oligo) Drugs Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oligonucleotide (Oligo) Drugs Markets in 2023
Figure 26. United States VS China: Oligonucleotide (Oligo) Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Oligonucleotide (Oligo) Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Oligonucleotide (Oligo) Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production Market Share 2023
Figure 30. China Based Manufacturers Oligonucleotide (Oligo) Drugs Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production Market Share 2023
Figure 32. World Oligonucleotide (Oligo) Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Type in 2023
Figure 34. siRNA
Figure 35. Antisense Oligonucleotide
Figure 36. World Oligonucleotide (Oligo) Drugs Production Market Share by Type (2019-2030)
Figure 37. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Type (2019-2030)
Figure 38. World Oligonucleotide (Oligo) Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Oligonucleotide (Oligo) Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Application in 2023
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Oligonucleotide (Oligo) Drugs Production Market Share by Application (2019-2030)
Figure 44. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Application (2019-2030)
Figure 45. World Oligonucleotide (Oligo) Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 46. Oligonucleotide (Oligo) Drugs Industry Chain
Figure 47. Oligonucleotide (Oligo) Drugs Procurement Model
Figure 48. Oligonucleotide (Oligo) Drugs Sales Model
Figure 49. Oligonucleotide (Oligo) Drugs Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
Table 1. World Oligonucleotide (Oligo) Drugs Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Oligonucleotide (Oligo) Drugs Production Value by Region (2019-2024) & (USD Million)
Table 3. World Oligonucleotide (Oligo) Drugs Production Value by Region (2025-2030) & (USD Million)
Table 4. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Region (2019-2024)
Table 5. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Region (2025-2030)
Table 6. World Oligonucleotide (Oligo) Drugs Production by Region (2019-2024) & (K Units)
Table 7. World Oligonucleotide (Oligo) Drugs Production by Region (2025-2030) & (K Units)
Table 8. World Oligonucleotide (Oligo) Drugs Production Market Share by Region (2019-2024)
Table 9. World Oligonucleotide (Oligo) Drugs Production Market Share by Region (2025-2030)
Table 10. World Oligonucleotide (Oligo) Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Oligonucleotide (Oligo) Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Oligonucleotide (Oligo) Drugs Major Market Trends
Table 13. World Oligonucleotide (Oligo) Drugs Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Oligonucleotide (Oligo) Drugs Consumption by Region (2019-2024) & (K Units)
Table 15. World Oligonucleotide (Oligo) Drugs Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Oligonucleotide (Oligo) Drugs Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Oligonucleotide (Oligo) Drugs Producers in 2023
Table 18. World Oligonucleotide (Oligo) Drugs Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Oligonucleotide (Oligo) Drugs Producers in 2023
Table 20. World Oligonucleotide (Oligo) Drugs Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Oligonucleotide (Oligo) Drugs Company Evaluation Quadrant
Table 22. World Oligonucleotide (Oligo) Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Oligonucleotide (Oligo) Drugs Production Site of Key Manufacturer
Table 24. Oligonucleotide (Oligo) Drugs Market: Company Product Type Footprint
Table 25. Oligonucleotide (Oligo) Drugs Market: Company Product Application Footprint
Table 26. Oligonucleotide (Oligo) Drugs Competitive Factors
Table 27. Oligonucleotide (Oligo) Drugs New Entrant and Capacity Expansion Plans
Table 28. Oligonucleotide (Oligo) Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Oligonucleotide (Oligo) Drugs Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Oligonucleotide (Oligo) Drugs Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Oligonucleotide (Oligo) Drugs Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Oligonucleotide (Oligo) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production Market Share (2019-2024)
Table 37. China Based Oligonucleotide (Oligo) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Oligonucleotide (Oligo) Drugs Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Oligonucleotide (Oligo) Drugs Production Market Share (2019-2024)
Table 42. Rest of World Based Oligonucleotide (Oligo) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production Market Share (2019-2024)
Table 47. World Oligonucleotide (Oligo) Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Oligonucleotide (Oligo) Drugs Production by Type (2019-2024) & (K Units)
Table 49. World Oligonucleotide (Oligo) Drugs Production by Type (2025-2030) & (K Units)
Table 50. World Oligonucleotide (Oligo) Drugs Production Value by Type (2019-2024) & (USD Million)
Table 51. World Oligonucleotide (Oligo) Drugs Production Value by Type (2025-2030) & (USD Million)
Table 52. World Oligonucleotide (Oligo) Drugs Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Oligonucleotide (Oligo) Drugs Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Oligonucleotide (Oligo) Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Oligonucleotide (Oligo) Drugs Production by Application (2019-2024) & (K Units)
Table 56. World Oligonucleotide (Oligo) Drugs Production by Application (2025-2030) & (K Units)
Table 57. World Oligonucleotide (Oligo) Drugs Production Value by Application (2019-2024) & (USD Million)
Table 58. World Oligonucleotide (Oligo) Drugs Production Value by Application (2025-2030) & (USD Million)
Table 59. World Oligonucleotide (Oligo) Drugs Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Oligonucleotide (Oligo) Drugs Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Lonis Basic Information, Manufacturing Base and Competitors
Table 62. Lonis Major Business
Table 63. Lonis Oligonucleotide (Oligo) Drugs Product and Services
Table 64. Lonis Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Lonis Recent Developments/Updates
Table 66. Lonis Competitive Strengths & Weaknesses
Table 67. Biogen Basic Information, Manufacturing Base and Competitors
Table 68. Biogen Major Business
Table 69. Biogen Oligonucleotide (Oligo) Drugs Product and Services
Table 70. Biogen Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Biogen Recent Developments/Updates
Table 72. Biogen Competitive Strengths & Weaknesses
Table 73. Sarepta Basic Information, Manufacturing Base and Competitors
Table 74. Sarepta Major Business
Table 75. Sarepta Oligonucleotide (Oligo) Drugs Product and Services
Table 76. Sarepta Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Sarepta Recent Developments/Updates
Table 78. Sarepta Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Oligonucleotide (Oligo) Drugs Product and Services
Table 82. Novartis Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Antisense Therapeutics Basic Information, Manufacturing Base and Competitors
Table 86. Antisense Therapeutics Major Business
Table 87. Antisense Therapeutics Oligonucleotide (Oligo) Drugs Product and Services
Table 88. Antisense Therapeutics Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Antisense Therapeutics Recent Developments/Updates
Table 90. Antisense Therapeutics Competitive Strengths & Weaknesses
Table 91. Akcea Basic Information, Manufacturing Base and Competitors
Table 92. Akcea Major Business
Table 93. Akcea Oligonucleotide (Oligo) Drugs Product and Services
Table 94. Akcea Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Akcea Recent Developments/Updates
Table 96. Akcea Competitive Strengths & Weaknesses
Table 97. Ruibo Biotechnology Basic Information, Manufacturing Base and Competitors
Table 98. Ruibo Biotechnology Major Business
Table 99. Ruibo Biotechnology Oligonucleotide (Oligo) Drugs Product and Services
Table 100. Ruibo Biotechnology Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Ruibo Biotechnology Recent Developments/Updates
Table 102. Ruibo Biotechnology Competitive Strengths & Weaknesses
Table 103. Inois Basic Information, Manufacturing Base and Competitors
Table 104. Inois Major Business
Table 105. Inois Oligonucleotide (Oligo) Drugs Product and Services
Table 106. Inois Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Inois Recent Developments/Updates
Table 108. Inois Competitive Strengths & Weaknesses
Table 109. Therapeutics Inc. Basic Information, Manufacturing Base and Competitors
Table 110. Therapeutics Inc. Major Business
Table 111. Therapeutics Inc. Oligonucleotide (Oligo) Drugs Product and Services
Table 112. Therapeutics Inc. Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Therapeutics Inc. Recent Developments/Updates
Table 114. Sanofi Basic Information, Manufacturing Base and Competitors
Table 115. Sanofi Major Business
Table 116. Sanofi Oligonucleotide (Oligo) Drugs Product and Services
Table 117. Sanofi Oligonucleotide (Oligo) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 118. Global Key Players of Oligonucleotide (Oligo) Drugs Upstream (Raw Materials)
Table 119. Oligonucleotide (Oligo) Drugs Typical Customers
Table 120. Oligonucleotide (Oligo) Drugs Typical Distributors
LIST OF FIGURE
Figure 1. Oligonucleotide (Oligo) Drugs Picture
Figure 2. World Oligonucleotide (Oligo) Drugs Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Oligonucleotide (Oligo) Drugs Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Oligonucleotide (Oligo) Drugs Production (2019-2030) & (K Units)
Figure 5. World Oligonucleotide (Oligo) Drugs Average Price (2019-2030) & (US$/Unit)
Figure 6. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Region (2019-2030)
Figure 7. World Oligonucleotide (Oligo) Drugs Production Market Share by Region (2019-2030)
Figure 8. North America Oligonucleotide (Oligo) Drugs Production (2019-2030) & (K Units)
Figure 9. Europe Oligonucleotide (Oligo) Drugs Production (2019-2030) & (K Units)
Figure 10. China Oligonucleotide (Oligo) Drugs Production (2019-2030) & (K Units)
Figure 11. Japan Oligonucleotide (Oligo) Drugs Production (2019-2030) & (K Units)
Figure 12. Oligonucleotide (Oligo) Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 15. World Oligonucleotide (Oligo) Drugs Consumption Market Share by Region (2019-2030)
Figure 16. United States Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 17. China Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 18. Europe Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 19. Japan Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 20. South Korea Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 22. India Oligonucleotide (Oligo) Drugs Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Oligonucleotide (Oligo) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Oligonucleotide (Oligo) Drugs Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Oligonucleotide (Oligo) Drugs Markets in 2023
Figure 26. United States VS China: Oligonucleotide (Oligo) Drugs Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Oligonucleotide (Oligo) Drugs Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Oligonucleotide (Oligo) Drugs Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Oligonucleotide (Oligo) Drugs Production Market Share 2023
Figure 30. China Based Manufacturers Oligonucleotide (Oligo) Drugs Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Oligonucleotide (Oligo) Drugs Production Market Share 2023
Figure 32. World Oligonucleotide (Oligo) Drugs Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Type in 2023
Figure 34. siRNA
Figure 35. Antisense Oligonucleotide
Figure 36. World Oligonucleotide (Oligo) Drugs Production Market Share by Type (2019-2030)
Figure 37. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Type (2019-2030)
Figure 38. World Oligonucleotide (Oligo) Drugs Average Price by Type (2019-2030) & (US$/Unit)
Figure 39. World Oligonucleotide (Oligo) Drugs Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 40. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Application in 2023
Figure 41. Hospital
Figure 42. Clinic
Figure 43. World Oligonucleotide (Oligo) Drugs Production Market Share by Application (2019-2030)
Figure 44. World Oligonucleotide (Oligo) Drugs Production Value Market Share by Application (2019-2030)
Figure 45. World Oligonucleotide (Oligo) Drugs Average Price by Application (2019-2030) & (US$/Unit)
Figure 46. Oligonucleotide (Oligo) Drugs Industry Chain
Figure 47. Oligonucleotide (Oligo) Drugs Procurement Model
Figure 48. Oligonucleotide (Oligo) Drugs Sales Model
Figure 49. Oligonucleotide (Oligo) Drugs Sales Channels, Direct Sales, and Distribution
Figure 50. Methodology
Figure 51. Research Process and Data Source
